
Source briefing
Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 24, Status: Authorised
Read →
Source briefing
Enabling equitable open access to commercially funded research publications
by Anja Schmidt, Christopher C. Winchester, Catherine Skobe, Diane R. Stothard, Eric Topol Pharmaceutical companies fund much biomedical research, yet many journals restrict open access publishing options for peer-reviewed articles reporting commercially funded research. Expanded publishing options, such…
Read →
Source briefing
A clinical decision support tool for accurate hip fracture prediction: A nationwide cohort study
by Kristian F. Axelsson, Henrik Litsne, Konstantinos Konstantinou, Hussnain Khalid, Aldina Pivodic, Mattias Lorentzon Background Although hip fractures are commonly associated with functional decline, increased morbidity, and mortality, accurate models for both short- and long-term prediction that do…
Read →
Source briefing
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 4, Status: Authorised
Read →
Source briefing
Tackling antimicrobial resistance: Information for animal health practitioners
Tackling antimicrobial resistance: Information for animal health practitioners
Read →
Source briefing
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 32, Status: Authorised
Human medicines European public assessment report (EPAR): Vyndaqel, tafamidis, Date of authorisation: 16/11/2011, Revision: 32, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of authorisation: 06/05/2026, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of authorisation: 06/05/2026, Revision: 1, Status: Authorised
Read →
Source briefing
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 3, Status: Authorised
Read →
Source briefing
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment
Read →
Source briefing
Estimates of global burden of snakebite: A literature review and geostatistical modelling study
by Dileepa Senajith Ediriweera, Anuradhani Kasturiratne, Arunasalam Pathmeswaran, Ymkje Stienstra, Gerardo Martín, Takuya Iwamura, Kris A. Murray, Hithanadura Janaka de Silva, Peter John Diggle, David Griffith Lalloo Background Snake envenoming (SE) remains an important public health problem, disproportionately…
Read →